390 related articles for article (PubMed ID: 11343046)
1. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
Nixon GM; Armstrong DS; Carzino R; Carlin JB; Olinsky A; Robertson CF; Grimwood K
J Pediatr; 2001 May; 138(5):699-704. PubMed ID: 11343046
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
[TBL] [Abstract][Full Text] [Related]
3. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use.
McPhail GL; Acton JD; Fenchel MC; Amin RS; Seid M
J Pediatr; 2008 Dec; 153(6):752-7. PubMed ID: 18760423
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
[TBL] [Abstract][Full Text] [Related]
6. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection.
Johansen HK; Nørregaard L; Gøtzsche PC; Pressler T; Koch C; Høiby N
Pediatr Pulmonol; 2004 May; 37(5):427-32. PubMed ID: 15095326
[TBL] [Abstract][Full Text] [Related]
9. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
10. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.
Ratjen F; Munck A; Kho P; Angyalosi G;
Thorax; 2010 Apr; 65(4):286-91. PubMed ID: 19996339
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.
Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK
Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286
[TBL] [Abstract][Full Text] [Related]
13. [Early antibiotic treatment for eradication of initial infection by Pseudomonas aeruginosa in patients with cystic fibrosis].
Giugno H; Castaños C; Lubatti A; Pinheiro JL; Hernández C; González Pena H
Arch Argent Pediatr; 2010 Apr; 108(2):141-7. PubMed ID: 20467710
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
15. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E
Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978
[TBL] [Abstract][Full Text] [Related]
16. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R; Champion A; Reid DW
Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
[TBL] [Abstract][Full Text] [Related]
17. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
18. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study.
Munck A; Gérardin M; Alberti C; Ajzenman C; Lebourgeois M; Aigrain Y; Navarro J
J Pediatr Surg; 2006 Sep; 41(9):1556-60. PubMed ID: 16952591
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.
Maselli JH; Sontag MK; Norris JM; MacKenzie T; Wagener JS; Accurso FJ
Pediatr Pulmonol; 2003 Apr; 35(4):257-62. PubMed ID: 12629621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
